Kai Van Lieshout discusses how AI scribes are transforming clinical practice, presenting both human stories and empirical evidence to show their impact on medical practitioners and the patient experience.
Prof Mikael S Hedenqvist and Dr Oisik Das from KTH Royal Institute of Technology in Sweden explain self-reinforced gluten polymers and why they are a step towards a true biocomposite
Markus Hautala, Head of Blockchain Solutions at Tieto argues that the public sector holds the keys to building a digital Europe, including why seamless...
Setthivoine You from the Department of Aeronautics & Astronautics at the University of Washington shares his insights into the intriguing world of self-organisation in plasmas
Lithuania exceeds container return rate expectations as TOMRA supports new state-of-the-art deposit system, as the firm’s Lorraine Dundon, VP Head of Group Brand & Corporate Communications reveals
The Behavioural Science Consortium supplies expertise that benefits government policy and services via their Behavioural Insights Framework, as this joint article from Sheffield Hallam University & The University of Manchester reveals
Marcel van Velthoven from ZNAPZ and Frans van Helden of ORTEC explain how to optimise business results for the rail industry by means of asset management to make the right decision
Bradley Moore, CEO of GCAC discusses how artificial intelligence and blockchain (trusted data) solve the paradox of limited medical cannabis data and anecdotal user information
Professor Robert Aiken, Research Crop Scientist from Northwest Research–Extension Center provides his expert thoughts on the fascinating global research taking place on drought, including the vital role of satellite imagery
Vacant property expert, Stuart Woolgar, CEO of Global Guardians, discusses the country’s current housing crisis and the section of people who cannot buy, nor are they eligible for social housing
Associate Professor and Director of Medical School Curriculum at the University of Illinois, Dr Ahlke Heydemann underlines Duchenne muscular dystrophy (DMD) – a debilitating, progressive muscle weakening disease.
The current state of metabolomics research and application in Acute Myeloid Leukaemia is placed under the spotlight by Bradley Stockard and Jatinder Lamba from Department of Pharmacotherapy and Translational Research, University of Florida
